TSL2109 Capsules

· Tasly Pharmaceutical Group Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TSL2109 Capsules, covering 2026-04-07 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: TSL2109 Capsules in Advanced Solid Tumor Patients: Safety, Tolerability, PK and Preliminary Efficacy [Phase 1]